The JASMINE Study Polymyositis [PM] and Dermatomyositis [DM] Clinical Trial Sign Up Now

About the “Jasmine” Study

A Clinical Research Study to investigate the efficacy and safety of an investigational medicinal product(s) (IMP(s) called Anifrolumab. Enrolling Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis [PM] and Dermatomyositis [DM]), between the ages of 18-75 (inclusive).

  • If you live with muscle weakness or skin symptoms from DM or PM.
  • If current treatment hasn’t fully helped your symptoms, you may qualify for a research study evaluating a potential new treatment option.
  • There is no cost to participate

Qualified participants will receive compensation for their travel.

Start the Application
to See If You May Be
Eligible to Participate

Sign Up Now

You may qualify if you:

Are 18 - 75 years old, inclusive
have been diagnosed with plymyositis (pm) or dermatomyositis (dm)
Are 18 - 75 years old, inclusive
have been diagnosed with plymyositis (pm) or dermatomyositis (dm)

Start the Application:

To see if you may be eligible to

participate, please fill out the

following form

Sign Up Now